Leukadherin1 (LA1) is used for the pharmacological activation of CD11b, which can synergistically inhibit the growth of CL66-LUc breast tumors and human MDA-MB-231 breast xenograft tumors [117]. The gene discussed is ITGAM; the disease is neoplasm.